Inhibition of avian-origin influenza A(H7N9) virus by the novel cap-dependent endonuclease inhibitor baloxavir marboxil-Reference-Cited by-同舟云学术

Inhibition of avian-origin influenza A(H7N9) virus by the novel cap-dependent endonuclease inhibitor baloxavir marboxil

Published:2019-03-05 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Taniguchi Keiichi,Ando Yoshinori,Nobori Haruaki,Toba Shinsuke,Noshi Takeshi,Kobayashi Masanori,Kawai Makoto,Yoshida Ryu,Sato Akihiko,Shishido Takao,Naito Akira,Matsuno Keita^ORCID,Okamatsu Masatoshi,Sakoda Yoshihiro^ORCID,Kida Hiroshi

Funder

All works reported here were financially supported by Shionogi & Co., Ltd..

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-39683-4.pdf

Reference64 articles.

1. Taubenberger, J. K. & Morens, D. M. Influenza: the once and future pandemic. Public Health Rep. 125, 16–26 (2010).

2. Su, S. et al. Epidemiology, Evolution, and Pathogenesis of H7N9 Influenza Viruses in Five Epidemic Waves since 2013 in China. Trends Microbiol. 25, 713–728 (2017).

3. Gao, R. et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N. Engl. J. Med. 368, 1888–97 (2013).

4. Zaraket, H. et al. Mammalian adaptation of influenza A(H7N9) virus is limited by a narrow genetic bottleneck. Nat. Commun. 6, 1–10 (2015).

5. Watanabe, T. et al. Characterization of H7N9 influenza A viruses isolated from humans. Nature 501, 551–555 (2013).

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world effectiveness and safety of Baloxavir Marboxil or Oseltamivir in outpatients with uncomplicated influenza A: an ambispective, observational, multi-center study;Frontiers in Microbiology;2024-07-23

2. FOUR-WEEK ORAL ADMINISTRATION OF BALOXAVIR MARBOXIL AS AN ANTI-INFLUENZA VIRUS DRUG SHOWS NO TOXICITY IN CHICKENS;Journal of Zoo and Wildlife Medicine;2024-06-13

3. The impact of PA/I38 substitutions and PA polymorphisms on the susceptibility of zoonotic influenza A viruses to baloxavir;Archives of Virology;2024-01-12

4. Baloxavir marboxil use for critical human infection of avian influenza A H5N6 virus;2023-09-05

5. In Vivo Antiviral Activity of Baloxavir against PA/I38T-Substituted Influenza A Viruses at Clinically Relevant Doses;Viruses;2023-05-11